Long-Acting Injectable Program is under clinical development by Intra-Cellular Therapies and currently in Phase I for Schizoaffective Disorder.

Researchers from Washington University found a common condition could make you more of a liability on the road as you age.

Older adults with major depressive disorder (MDD) demonstrate distinct and riskier driving behaviors than those withou ...

In this longitudinal cohort study of older drivers, adults with major depressive disorder demonstrated distinct and riskier driving ...

Here’s a look at the best and worst states in each of our four data categories: mental health provider ratio, percentage of ...

Find Psychotic Break Latest News, Videos & Pictures on Psychotic Break and see latest updates, news, information from NDTV.COM. Explore more on Psychotic Break.

White matter alterations within the brain are associated with cognitive impairment among individuals with and without major ...

Nelivaptan (NB-415, SSR-149415) is under development for the treatment of depression including major depressive disorder (MDD). The drug candidate targets vasopressin receptor 1B ( (V1bR). It is ...

From 2017 to 2021, pediatric depression and anxiety rates increased by 55.6% and 31.1%, respectively. Rates were higher ...

Neumora Therapeutics to release phase 3 data on Navacaprant for MDD treatment in 2024. Check out NMRA's catalysts that might ...

MindMed currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks from the biotech sector are Castle Biosciences, Inc. CSTL, CytomX Therapeutics CTMX and Spero Therapeutics SPRO, each ...